ES

Elizabeth Schwarzbach

Chief Business Officer

BigHat Biosciences

New York, New York


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
BigHat Biosciences
Industry
research
Employees
120.0
Seniority
C suite
Annual Revenue
7200000.0
Total Funding
99302511.0
Latest Funding
Series B

Technologies

Gmail Google Apps Microsoft Office 365 Amazon AWS Outlook Google Tag Manager ShareThis Mobile Friendly WordPress.org YouTube Remote AI

Keywords

biotechnology research antibody design machine learning biologics therapeutics synthetic biology biopharmaceuticals drug discovery clinical development next-generation antibodies biophysics high-speed wet lab antibody therapies automated assays recombinant antibodies multi-objective optimization targeted therapies disease biology therapeutic proteins affinity optimization immunogenicity clinical safety efficacy biocompatibility therapeutic index personalized medicine protein engineering disease activity cell-based assays biochemical properties functional assays next-gen antibody formats therapeutic innovation collaborative research compounds optimization pipeline development vhh antibodies adc technologies target-specific treatments epitope-specific hits protein synthesis discovery engine interdisciplinary teams ai-driven design data science in biomedicine partnership programs therapeutic targets drug-response evaluation artificial intelligence information technology & services biotechnology

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans